FGF-1 protein injection for chronic chest pain
Part of Heart & circulation clinical trials.
This trial tests whether injecting a protein called FGF-1 into the heart can help relieve chronic chest pain (angina) in people who are not good candidates for stents or bypass surgery. The goal is to improve blood flow and reduce pain without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to have had stable chest pain (angina) for at least 3 months.
- Your angina must be severe (CCS class 3 or 4) despite being on at least one heart medication (like a beta-blocker or nitrate).
- Your doctor must have said that a stent or bypass surgery is not a good option for you.
- Your heart function (ejection fraction) must be at least 30% – your doctor can check this.
- You must be able to walk on a treadmill for 3–9 minutes (on a standard test).
- You cannot have certain eye problems, uncontrolled diabetes, or a history of cancer (except some skin cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device placed in a heart vein (the coronary sinus) to improve blood flow and reduce chest pain in people with coronary microvascular dysfunction (small blood vessel disease). It aims to help those who still have symptoms despite taking heart medications.
This trial tests an injection of FGF-1, a protein that may help grow new blood vessels, to improve leg pain and walking ability in people with blocked arteries in the legs. It is for those with stable claudication (leg pain when walking) and aims to increase blood flow and reduce pain.
This trial tests a new gene therapy (XC001) delivered through a thin tube into your heart's blood vessels. It aims to grow new blood vessels to relieve chest pain in people with chronic angina who have no other treatment options.
This Phase 2 trial tests whether stem cells placed into the heart artery can safely reduce symptoms in people with “refractory” angina (chest pain) despite maximum heart-healthy medication. You may qualify if your chest pain is limiting your activity and other heart procedures (stents/bypass) aren’t possible or are too risky.
This study looks at how to personalize treatment for people with angina (chest pain) by measuring how well blood flows through the heart’s small vessels and the main arteries during a procedure. It may help doctors choose the right approach after your coronary angiography (heart artery imaging).
This trial studies how heart disease affects the heart using heart imaging, and looks at people with chest pain/angina or heart failure with preserved pumping strength (HFpEF). It may help doctors better understand what’s driving symptoms and how best to evaluate these conditions.
Hear when a new Coronary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.